Single-cell studies are essential for biochemical characterization of heterogeneous cell behaviors. However, studying direct correlation between cell input (transfection) and output (biochemical analysis) is still challenging due to lack of high throughpu methodologies with cell selectivity and high enough sensitivity. The tool proposed here is a microwell device that will allow temporal sampling and analysis of internal biomolecules, with the additional functionality of activating cells by delivering genes, drugs, or other molecules when appropriate for the biological problem. This tool would enable fundamental studies of biological variability, input- output relationships that control mechanistic pathways, and with multiplexed automation, could serve as a drug screening platform. The major innovations of the proposed device include (1) isolation of 1,000 individual single cells in a microwell array, (2) long-term cell culture on a micro device, (3) temporal transfection and extraction of biomolecules from a target cell in a minimally invasive manner, (4) highly sensitive detection of bio samples from cell cytosol, and (5) (in Phase II) automated operation and data acquisition. To achieve the highly innovative features, the proposed micro device incorporates a PDMS-based microwell array with integrated microfluidic channels, microelectrodes, and an antibody microarray.

Public Health Relevance

The tool proposed here is a microwell-based device that will allow temporal single-cell sampling and analysis of internal biomolecules, with the additional functionality of delivering genes or drugs. This would enable fundamental studies of biological variability and mechanistic pathways, and it could serve as a drug screening platform, bringing new capabilities for the fields of cell biology and biotechnology to discover disease mechanisms and potential therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM110893-01
Application #
8714775
Study Section
Special Emphasis Panel (ZRG1-IMST-M (13))
Program Officer
Edmonds, Charles G
Project Start
2014-09-20
Project End
2015-09-19
Budget Start
2014-09-20
Budget End
2015-09-19
Support Year
1
Fiscal Year
2014
Total Cost
$150,001
Indirect Cost
Name
Infinitesimal, LLC
Department
Type
DUNS #
963953844
City
Skokie
State
IL
Country
United States
Zip Code
60077